Home » Topics » Regulatory » Patents

Patents
RSS

Amgen discovers beta-secretase inhibitors

Feb. 21, 2017

Novel TNF-alpha antagonists synthesized at Bristol-Myers Squibb

Feb. 21, 2017

NantWorks/Nant Holdings patent thiosemicarbazone derivatives

Feb. 21, 2017

Samumed identifies novel Wnt signaling and IL-6 production inhibitors

Feb. 21, 2017

Progenra describes new USP7/USP47 inhibitors

Feb. 20, 2017

Toyama Chemical, Fujifilm identify novel C-X-C motif chemokine 10 inhibitors

Feb. 20, 2017

Allergan discloses new fMet-Leu-Phe/N-formyl peptide receptor 2 agonists

Feb. 17, 2017

Astellas Pharma describes novel MC4 receptor agonists

Feb. 17, 2017

Catalyst Therapeutics identifies new bromodomain inhibitors

Feb. 17, 2017

The University of Nantes presents new antifungal/antiparasitic agents.

Feb. 17, 2017

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...